Evidence map›Paper›PMID 24360274›Full record

ArticleCell2013

Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation.

Kyong-Rim Kieffer-Kwon, Zhonghui Tang, Ewy Mathe, Jason Qian, Myong-Hee Sung, Guoliang Li, Wolfgang Resch, Songjoon Baek, Nathanael Pruett, Lars Grøntved and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 218 papers.

0numbers the graph read from it
0cells of the map it votes in
218citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

218 citing papers in PubMed, 335 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. DNA Methylation ofBiology · 2025
    Article
  10. Article
  11. Article
  12. The LIM-domain-only protein LMO2 and its binding partner LDB1 are differentially required for class switch recombination.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Enhancer Arrays Regulating Developmental Genes: Sox2 Enhancers as a Paradigm.Results and problems in cell differentiation · 2024
    Article
  18. AGO2 silences mobile transposons in the nucleus of quiescent cells.Nature structural & molecular biology · 2023
    Article
  19. Article
  20. Article

158 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 2 countries.

Kyong-Rim Kieffer-KwonGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Zhonghui TangThe Jackson Laboratory for Genomic Medicine, and Department of Genetic and Development Biology, University of Connecticut, 400 Farmington, CT 06030, USA.
Ewy MatheGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Jason QianGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Myong-Hee SungLaboratory of Receptor Biology and Gene Expression, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Guoliang LiThe Jackson Laboratory for Genomic Medicine, and Department of Genetic and Development Biology, University of Connecticut, 400 Farmington, CT 06030, USA.
Wolfgang ReschGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Songjoon BaekLaboratory of Receptor Biology and Gene Expression, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Nathanael PruettGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Lars GrøntvedLaboratory of Receptor Biology and Gene Expression, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Laura VianGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Steevenson NelsonGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Hossein ZareLaboratory of Muscle Stem Cells and Gene Regulation, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Ofir HakimBar-Ilan University, Ramat-Gan 5290002, Israel.
Deepak ReyonMolecular Pathology Unit, Center for Computational and Integrative Biology, and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA; Department of Pathology, Harvard Medical School, Boston, MA 02115 USA.
Arito YamaneGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Hirotaka NakahashiGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Alexander L KovalchukLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Jizhong ZouLaboratory of Stem Cell Biology, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
J Keith JoungMolecular Pathology Unit, Center for Computational and Integrative Biology, and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA; Department of Pathology, Harvard Medical School, Boston, MA 02115 USA.
Vittorio SartorelliLaboratory of Muscle Stem Cells and Gene Regulation, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA.
Chia-Lin WeiDOE Joint Genome Institute, 2800 Mitchell Drive, Walnut Creek, CA 94598, USA.
Xiaoan RuanThe Jackson Laboratory for Genomic Medicine, and Department of Genetic and Development Biology, University of Connecticut, 400 Farmington, CT 06030, USA.
Gordon L HagerLaboratory of Receptor Biology and Gene Expression, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Yijun RuanThe Jackson Laboratory for Genomic Medicine, and Department of Genetic and Development Biology, University of Connecticut, 400 Farmington, CT 06030, USA.
Rafael CasellasGenomics and Immunity, NIAMS, National Institutes of Health, Bethesda, MD 20892, USA; Center of Cancer Research, NCI, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: rafael.casellas@nih.gov.
National Institutes of Health · USNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USJackson Laboratory · USUniversity of Connecticut · USBar-Ilan University · ILCenter for Cancer Research · USJoint Genome Institute · USMassachusetts General Hospital · USNational Institute of Allergy and Infectious Diseases · US

Funding

RAG and AID biologyZIAAR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$44.8M
Causal Transcriptional Consequences of Human Genetic VariationP50HG005550 · NHGRI · HARVARD MEDICAL SCHOOL · PI CHURCH, GEORGE M · 2010 to 2014
$19.0M
SIRT1 in Skeletal Muscle Development, Regeneration, and AtrophyZIAAR041164 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI SARTORELLI, VITTORIO · 2009 to 2025
$15.3M
Function of Steroid Receptors in Subcellular CompartmentsZIABC010027 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON L · 2009 to 2025
$8.7M
Advancing stem cell technologies using engineered zinc finger proteinsDP1GM105378 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI JOUNG, J. KEITH · 2012 to 2014
$2.6M
Transcription, Chromatin and DNA RepairZ01AR041149 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI CASELLAS, RAFAEL C · 2005 to 2008
$1.8M
AID biologyZ01AR041148 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI CASELLAS, RAFAEL C · 2005 to 2008
$1.8M
Intramural NIH HHS Z01 AR041148Intramural NIH HHS Z01 AR041149NCCDPHP CDC HHS DP1 GM105378NHGRI NIH HHS P50 HG005550NIGMS NIH HHS DP1 GM105378
6 · The paper itself

Abstract

A key finding of the ENCODE project is that the enhancer landscape of mammalian cells undergoes marked alterations during ontogeny. However, the nature and extent of these changes are unclear. As part of the NIH Mouse Regulome Project, we here combined DNaseI hypersensitivity, ChIP-seq, and ChIA-PET technologies to map the promoter-enhancer interactomes of pluripotent ES cells and differentiated B lymphocytes. We confirm that enhancer usage varies widely across tissues. Unexpectedly, we find that this feature extends to broadly transcribed genes, including Myc and Pim1 cell-cycle regulators, which associate with an entirely different set of enhancers in ES and B cells. By means of high-resolution CpG methylomes, genome editing, and digital footprinting, we show that these enhancers recruit lineage-determining factors. Furthermore, we demonstrate that the turning on and off of enhancers during development correlates with promoter activity. We propose that organisms rely on a dynamic enhancer landscape to control basic cellular functions in a tissue-specific manner.

Indexed as

Enhancer Elements, GeneticGene Expression Regulation, DevelopmentalPromoter Regions, GeneticRegulonAnimalsB-LymphocytesCell LineageCells, CulturedCpG IslandsDNA MethylationEmbryonic Stem CellsGenetic TechniquesMiceOrgan SpecificityRNA, Long NoncodingTranscription FactorsRNA, Long NoncodingTranscription Factors

Identifiers

PMID24360274
PMCPMC3905448
OpenAlexW2116147219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.